Strategy. Executed.
Senior strategy and transformation expertise — without the agency overhead. Two mandates per year.
Having a strategy
is not the problem.
The McKinsey research is unambiguous: 70% of all strategic initiatives fail. Not because the analysis was poor. Not because the strategy was wrong. Because the decisions made along the way — under pressure, in meetings, when it gets hard — were distorted by the same cognitive shortcuts that have governed human behaviour for 200,000 years.
Your availability bias focuses on the information already in the room and misses what isn't. Your confirmation bias finds the evidence that supports the plan you've already committed to. Your overconfidence bias underestimates what winning actually requires. And your loss aversion keeps you attached to a direction long after the signals have changed. Blockbuster. Blackberry. Kodak. None of them lacked smart people or sound analysis. They lacked a process designed to defeat the biases inside it.
of all strategic initiatives fail — not from poor analysis, but from poor process and unchallenged assumptions
McKinsey research: strategy process is six times more important than analysis quality in predicting outcomes
the number of decisions a person makes each day — over 95% fully automated, shaped by instincts built for a different world
The engagement model
is the problem
no one names.
Most consultants exit at the slide deck. Most executives inherit a strategy they didn't build. Neither of them is in the room when the decisions get hard. That gap — between strategy design and the first six months of execution — is where 70% of the value disappears.
Stratecution enters at the beginning of that gap and stays until it closes. Not as a facilitator. Not as a coordinator. As an embedded executive with actual mandate, actual decision authority, and a designed exit — when the organisation can carry the work alone.
| What most strategies get | What Stratecution does |
|---|---|
| Strategy ends with the slide deck | Execution starts day one. Exit triggered by momentum. |
| Standard frameworks | Diagnostics first, real solutions. |
| Coordination and facilitation | Actual mandate. Actual decisions. Actual accountability. |
| Fixed junior team | Two mandates per year. You get the expert – not a team who met on Tuesday. |
| Day-rate billing, open-ended scope | Fixed phase fee. Accountability to output, not hours. |
Two tracks.
One entry point:
the diagnosis.
Every engagement begins with a situation assessment — not to confirm the client's framing, but to find where the actual breakdown is. The track follows from that. The exit is always defined before we start.
For companies with strong internal execution teams and a strategy problem at the top. You need a clear view of the options, the architecture built and the choices made. Then you need us out of the way so your team can move.
- → Situation assessment and diagnostic
- → Strategic options and scenario modelling
- → Choice — the pathway and the trade-offs made explicit
- → Board sign-off and handover package
- → Exit
Matas: acquisition and organic growth strategy unlocking 25% revenue expansion.
ChangeGroup: corporate strategy and operating model delivering 30% uplift.
Red Bull: Overhauled digital business model delivering 100% revenue growth.
Track 1 is also the most common entry point for longer mandates.
For companies that need more than a strategy. They need someone to drive it through the phase where most strategies die — the first six months, when direction is still contested, the organisation hasn't committed, and the pressure to act is already real.
- → Diagnosis and strategic architecture
- → Capability assessment and gap plan
- → Early execution — decisions made, not facilitated
- → Organisation builds capability to carry the work
- → Exit trigger: when the programme meetings feel relaxed
BoConcept: entered as strategy advisor, evolved to interim CMO. Drove corporate and marketing strategy. 400% revenue growth.
Epinion: entered as strategy advisor, evolved to Managing Director. Led growth strategy and business model transformation.
Novo Nordisk: embedded in 6-SVP program to double manufacturing capacity. Defined structure, built insight, drove decisions.
The moment matters as much as the company.
Stratecution works best at a specific kind of inflection point — where the stakes are high, the direction is contested, and a senior executive with actual authority can change the outcome.
Danish-headquartered. 500M – 4B DKK revenue. Consumer products or life science. A leadership team that is capable and committed — but doesn't have the combination of strategic rigour and execution authority the moment requires.
Post-merger organisation doesn't know which direction to run. New CEO in the first 100 days needing a strategic architecture fast. A growth ambition with no clear pathway. A transformation program that stalled before starting.
Not "do we need a strategy?" Most companies have one. The question is: do we have someone with the authority, the rigour, and the independence to drive it through the part where most strategies die?
25 years. Two main
sectors. One standard.
Selected engagements across 25 years — as strategy advisor, interim executive and transformation lead. Named companies. Named outcomes.
Results are real, attributable and verifiable. No logo appears here that wasn't earned.
Led global commercial strategy across 50+ markets. Secured omnichannel technology investment driving DKK 1bn+ revenue uplift.
Strategy advisor to interim CMO. Corporate strategy, omnichannel strategy, brand repositioning, org redesign. Clean handover.
Strategy and innovation programmes for management talent across five consecutive years with consistent high ratings.
Led 6-SVP global programme to expand manufacturing capacity in record time and transform procurement operating model.
Full corporate strategy program managing four different consultancies, first financial forecasting model and R&D organisational design.
Acquisition and organic growth strategy unlocking 25% revenue expansion. Built the pathway for Matas to scale its healthcare universe.
10+ years of senior commercial roles. Managed three $100M businesses in Europe, Latin America and Asia and turned from loss to massive profit.
Innovation strategy targeting 50% reduction in cost of energy for DONG to transition to one of the world's leading renewable energy companies.
International deal sourcing and investment decision bias training to accelerate PE portfolio value creation.
We are building
a better way
of making strategy.
What that means for growth, transformation, M&A, boards and the decisions that determine which 30% of strategies succeed.
When the world's largest companies reverse flagship strategic decisions, it isn't a failure of analysis. It's a failure of process. The cognitive patterns behind these reversals are predictable — and preventable.
Read on LinkedIn → Brand Strategy · 4 min readWhen financial discipline and strategic positioning point in opposite directions, fixing the numbers can accelerate the underlying problem.
Read → Disruption · 4 min readChristensen's disruption theory predicted exactly what happened to premium hearing aids. Knowing the theory and surviving it are two different things.
Read → Brand · 4 min readSwapping sterling silver for platinum-plated is not a materials decision. It is a positioning decision — and one with significant strategic stakes for a brand that has already repositioned once.
Read → M&A · 4 min readMost M&A analysis focuses on the deal mechanics. The more interesting question is what the acquirer is admitting about their organic growth ceiling.
Read → ESG & Strategy · 3 min readWhen incentive structures change, strategy follows. What Maersk's decision reveals about the limits of ESG as a strategic commitment mechanism.
Read →Every Tuesday morning — real companies, insider perspective, the kind of observation that makes you slightly uncomfortable. Which is usually a good sign.
Follow on LinkedIn →